Theseus Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Theseus Pharmaceuticals has a total shareholder equity of $224.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $234.6M and $10.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$205.12m |
| Equity | US$224.52m |
| Total liabilities | US$10.11m |
| Total assets | US$234.63m |
Recent financial health updates
Theseus Pharmaceuticals (NASDAQ:THRX) Is In A Good Position To Deliver On Growth Plans
Aug 18
Companies Like Theseus Pharmaceuticals (NASDAQ:THRX) Are In A Position To Invest In Growth
May 05Companies Like Theseus Pharmaceuticals (NASDAQ:THRX) Are In A Position To Invest In Growth
Dec 07Recent updates
Theseus Pharmaceuticals: Biotech Buyout Remains Attractive At $4.06 Because Of 2-Part CVR
Feb 01Theseus Pharmaceuticals (NASDAQ:THRX) Is In A Good Position To Deliver On Growth Plans
Aug 18Companies Like Theseus Pharmaceuticals (NASDAQ:THRX) Are In A Position To Invest In Growth
May 05Companies Like Theseus Pharmaceuticals (NASDAQ:THRX) Are In A Position To Invest In Growth
Dec 07Theseus Pharmaceuticals GAAP EPS of -$0.30 in-line
Aug 11Here's Why We're Not Too Worried About Theseus Pharmaceuticals' (NASDAQ:THRX) Cash Burn Situation
Apr 22Financial Position Analysis
Short Term Liabilities: THRX's short term assets ($209.6M) exceed its short term liabilities ($7.0M).
Long Term Liabilities: THRX's short term assets ($209.6M) exceed its long term liabilities ($3.1M).
Debt to Equity History and Analysis
Debt Level: THRX is debt free.
Reducing Debt: THRX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: THRX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: THRX has sufficient cash runway for 2.9 years if free cash flow continues to reduce at historical rates of 51.3% each year.